Gastric stem cell research and gastric organoids

Article information

Organoid. 2022;2.e27
Publication date (electronic) : 2022 December 25
doi :
Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
Correspondence to: Ki Taek Nam, DVM, PhD Severance Biomedical Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea E-mail:
Received 2022 May 30; Revised 2022 July 1; Accepted 2022 September 20.


The stomach is a complex organ lined with ordered epithelium consisting of different adult stem cell (ASC) pools. In the previous decade, research into gastric epithelial stem cells has been performed using lineage tracing methods, and several putative ASC markers in the gastric gland have been identified, although their roles in homeostasis maintenance and the origin of cancer remain to be clarified. With advances in gastric stem cell research, 3-dimensional (3D) organoid culture has been developed on the basis of in-depth insights into the control of stem cell self-renewal, proliferation, and differentiation. Since the initial report that single intestinal stem cells have the ability to generate long-lived 3D structures that exhibit budding forms and self-renewal, tissue-specific adaptations of this method have been established in various organs, such as the small intestine, colon, liver, and stomach. In the murine stomach, putative ASCs isolated from the corpus and antrum generate gastric organoids that can simulate organ-specific cells to some extent. In addition, a few trials have been conducted to generate long-lived 3D organoids using human-derived ASCs and pluripotent stem cells. We hope that this review will provide comprehensive knowledge on gastric stem cell research and gastric organoids.


The stomach is a digestive organ responsible for the mechanical and chemical digestion of food. Various physiological events, including acid secretion, mucin secretion, and hormone production, occur in specialized cells of the stomach [1]. Two glandular units, the corpus and antrum, harbor functional cells and constitute the epithelial layer of the stomach (Fig. 1). Unlike in humans, the murine stomach contains a non-glandular structure, called the forestomach, with stratified epithelial cells in the upper part of the corpus [1,2]. Varying types of mature cells are sequentially differentiated and make up the corpus and antrum (Fig. 1B). Mucin5AC (MUC5AC)-secreting pit cells, trefoil factor family 2 (TFF2), and GSII from Griffonia simplicifolia (GSII)-expressing mucous neck cells, H/K ATPase positive parietal cells, zymogenic granule-secreting chief cells, and enteroendocrine cells (G-cells, D-cells, and enterochromaffin-like cells) contribute to the physiological function of the gastric glands [3,4]. Those differentiated epithelial cells emerge from adult stem cells (ASCs) that exhibit diverse markers in specialized locations (Fig. 1B).

Fig. 1.

Illustrations of the human and mouse stomach. (A) Anatomy of the human and mouse stomach. (B) Images show the distribution of adult stem cells and functional units in the corpus and antrum. The defined molecular markers for adult stem cells and gastric lineage cells are marked in parentheses. Transit-amplifying (TA) cells are an undifferentiated subset in transition between stem cells and differentiated cells. eR1, Runx1 enhance element; GSII, lectin GS-II from Griffonia simplicifolia.

Since Hans Clevers’ group introduced intestinal organoid culture from single leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5)+ stem cells in 2009 [5], this novel method has been utilized in studies of various organs, including the colon [6], tongue [7], brain [8], gut [9], liver [10], and kidney [11]. Furthermore, organoid technology is being applied in regenerative medicine and drug discovery as a replacement for clinical research [12,13].

The gastric epithelium must self-renew its own structure because it constantly encounters a harsh environment [14]. Thus, several studies have focused on the identification of gastric stem cells and the construction of gastric organoids using populations thereof. The human and mouse stomach consists of 2 representative glandular structures that have distinct cellular lineages: the corpus and antrum [15]. The corpus is the main acid-producing region of the stomach, and gastric acid-secreting parietal cells are ablated during Helicobacter pylori or Helicobacter felis infection [16] or treatment with metaplasia-inducing chemicals (DMP-777, L-635, high-dose tamoxifen [HDT]) [17-19]. These injuries activate the ASCs responsible for mucosal recovery. The antrum gland contains gastrin-secreting endocrine cells, and gastric tumors predominantly develop in the antrum in response to treatment with a carcinogenic agent (N-methyl-N-nitrosourea, MNU) [20,21].

Stem cells are characterized by self-renewal and multi-potency. These specialized cells are crucial for maintaining tissue homeostasis and response to injury [22,23]. Gastric stem cells reside in the base of the antrum in both humans and mice, expressing distinct molecular markers such as LGR5, cholecystokinin 2 receptor (CCKR2), axis inhibition protein 2 (AXIN2), aquaporin-5 (AQP5), and leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1). Barker et al. [9] found that single LGR5+ cells from the antrum gland could generate gastric organoids, generating most antrum cell lineages. By contrast, the location of ASCs that maintain tissue homeostasis and contribute to gastric cancer in the corpus remains a matter of debate [3]. In the corpus, 2 known populations have been identified as putative ASCs. One is located in the isthmus region, where highly proliferating cells reside, and the other is located in the base of the gland, where a subset of mature chief cells act as quiescent "reserve” stem cells. A recent lineage tracing study demonstrated that single stem cells derived from both regions have the capacity to generate all corpus lineages.

Cancer stem cells (CSCs) are defined by their ability to self-renew and maintain a malignant tumor. Their characteristics are highly similar to the properties of stem cells in normal tissues. It has been believed that CSCs originate from stem cells rather than differentiated cells [24,25]. In gastric cancer progression, gastric stem cells act as the origin of cancer [26], developing spasmolytic polypeptide expressing metaplasia (SPEM) and intestinal metaplasia toward gastric cancer. Due to the low cost of breeding and high homologies with human genes, murine models have been broadly utilized in stem cell research as well as cancer research [27,28]. Indeed, SPEM has been noted in mice models, including those with H. pylori or H. felis infection [29,30]. Furthermore, human-resembling cancer could be recapitulated in stomach-specific transgenic mice [31]. A recent study also established metaplastic organoids using the murine dysplasia model [32], suggesting that organoids are a promising tool for studying gastric carcinogenesis. Collectively, this review aims to present a comprehensive range of knowledge on gastric stem cell research and stem cell-derived organoids in humans and mice.

Ethics statement: This study was a literature review of previously published studies and was therefore exempt from institutional review board approval.

Identification of gastric stem cell populations

A subset of antrum basal cells is responsible for self-renewal, proliferation capacity, and differentiation potential. Putative ASCs expressing distinct molecular markers are present in the base of the gland, and previous studies investigated their potential stem cell activity. In an early study, Barker et al. [9] found that LGR5, which is an R-spondin receptor and WNT target gene, was expressed in the very base of the gland and marked ASCs in the antrum. Using Lgr5-driven LacZ systems, they proved that single LGR5+ cells constructed the entire antrum gland within 7 to 10 days and their daughter cells expressed MUC5AC and gastrin. This tracing event persisted for 620 days, revealing the self-renewal activity and multi-potency of LGR5+ cells. Furthermore, considering the high expression of LGR5 in ASCs, researchers developed gastric disease models using an Lgr5-driven Cre-LoxP system [33,34]. A recent report showed that a subpopulation of LGR5+ cells strongly expressed AQP5. Of note, AQP5+ cells serve as potential CSCs in humans and mice [35]. Although LGR5+ cells play critical roles in maintaining tissue homeostasis [36], several studies have demonstrated the existence of LGR5-independent stem cell populations in the antrum. SRY-box transcription factor 2 (Sox2)+ cells also possess multi-potency, with the capability of generating all lineages of the corpus and antrum, but they do not co-localize with Lgr5 [37]. Recently, antrum stem cells controlled by gastrin-secreting G-cells were identified. This CCK2R+ stem cell pool resides in +4 antrum loci from the base of the gland (+0), is not co-localized with LGR5 (Fig. 1B), and has quiescent characteristics [20,38]. In addition, Lrig1, which was initially identified as a stem cell marker along with Lgr5 [39-41], also marks the quiescent stem cell pool in the lower part of the antrum gland [42,43].

Defining the ASCs and the origin of cancer is more complicated in the corpus than in the antrum because molecular makers overlap in 2 distinct regions (Fig. 1B) [3,44-46]. Reliable reports have shown that there are 2 distinct compartments where ASCs reside in the corpus gland and demonstrated that these cells contribute to regeneration and cancer development. As the cellular origin of gastric stem cells in the corpus remains a matter of debate, researchers are trying to identify a molecular marker that can distinguish the 2 compartments (Table 1) [9,20,34,35,37,38,42,43,47-50]. Previous studies have employed lineage tracing methods to investigate the existence of multipotent ASCs in the corpus epithelium.

Characteristics of stem cell-derived gastric organoids

It is generally believed that stem cells are the source of cancer due to their properties [51]. Since cells need to acquire multiple mutagenic events to convert to malignant cells, long-lived stem cells have a greater chance to become CSCs. Considerable evidence has suggested that mature chief cells trans-differentiate into pre-neoplastic cells and can be the origin of gastric cancer [19,45,52,53]. Supporting this, stem cell markers such as TNF receptor superfamily 19 (Troy) and Sox2 are strongly expressed in chief cells of the corpus [37,47]. Stange et al. [47] found that Troy+ chief cells act as “reserve stem cells” characterized by slow clonal expansion. The cells reproduce the entire gastric unit under conditions of both homeostasis and injury. Unlike the antrum, Troy+ chief cells in the corpus exhibited strong expression of Lgr5 in comparison with Troy- cells. Furthermore, basic helix-loop-helix family member a15 (Mist1), a granule maturation factor, marks mature chief cells as well as quiescent stem cells in the base of corpus [47]. Interestingly, Lgr5+ cells, which are known as a subpopulation of antrum stem cells, exist in the corpus gland of humans and mice [34,36]. Lgr5 is expressed in a subpopulation of chief cells; this specific subset acts as “reserve” stem cells, contributing to the regeneration of the gland after HDT-induced injury rather than in a homeostatic state [34]. Additionally, metaplastic lesions were promoted in Lgr5-driven Kras proto-oncogene, GTPas (Kras) mutant mice (Lgr5-2A-creERT2/KrasG12D), suggesting that Lgr5+ chief cells may be the origin of gastric cancer.

By contrast, several reports proposed the presence of ASCs in the isthmus region along with putative stem cell markers. In particular, Runx1 enhancer element (eR1)+ marks the proliferating progenitors in the isthmus, contributing to the maintenance of the gastric gland unit [48]. Moreover, a recent study revealed the existence of a unique ASC population expressing BMI1 proto-oncogene, polycomb ring finger (Bmi1) in the isthmus region. In the corpus, Bmi1+ cells represent the ASC population independent of Lgr5 and eR1 [50]. Hayakawa et al. [49] stated that quiescent stem cells exist in the isthmus cell region, but not in the chief cell region. In Mist1-driven confetti mice, a few Mist1+ isthmus cells expand their population and still produce gland units even 18 months after tamoxifen injection, and also act as the cellular origin of cancer. This is a contradictory result to previous reports that Mist1+ chief cells were responsible for maintaining homeostasis and developing cancer [45,47,52,53].

Han et al. [54] recently found that both isthmus stem cells and chief cells contributed to the maintenance of the corpus unit using marker-free lineage tracing (Rosa26-CreERT2; Confetti). Although basal corpus cells are slowly recycled, this ASC pool has the capacity to generate a mature gland. Thus, the isthmus region seems to be the central zone of proliferation, but it is apparent that there is another zone with the capability of self-renewal and multi-potency.

Taken together, ASCs exist in the gastric corpus and antrum in different regions, contributing to the maintenance of homeostasis, response to injury, the development of gastric cancer, and organoid formation. It is noteworthy that the ASC populations of the gastric unit share the same molecular markers or express distinct markers (Table 1).

Murine-derived gastric organoids

Unlike two-dimensional culture, 3-dimensional (3D) organoid culture has the advantage of reproducing functional units under in vitro conditions. Therefore, many approaches have been used to construct murine-derived gastric organoids using ASCs. As shown in Table 1, each organoid from diverse ASCs contains different gastric cell lineages (Table 1). Barker et al. [9] first reported that organoids derived from single LGR5+ cells in antrum could form a budding-structure and persist for 9 months. LGR5+ cells from the corpus and AQP5+ cells from the antrum successfully reproduced MUC5AC+ pit cells in a conditioned culture medium [34,35]. Among the cultured organoids, the corpus organoids derived from Troy+ chief cells and eR1+ isthmus cells exhibited the most diverse corpus cell lineages [47,48]. Lectin GSII+ mucus neck cells, gastric intrinsic factor (GIF)+ chief cells, and Muc5ac+ pit cells were generated from Troy-derived corpus organoids, and the differentiation was confirmed by immunofluorescence staining and reverse-transcription quantitative polymerase chain reaction [47]. In contrast to mucus neck cells and chief cells, gastric pit cell development was triggered in a medium without Wnt, noggin, and fibroblast growth factor (FGF)-10. Moreover, it is noteworthy that single CCK2R-derived organoids gave rise to Lgr5+ cells as well as differentiated cells [20].

Gastric parietal cells are unique cells in the corpus and play a critical role in gastric mucosal homeostasis through the secretion of growth factors and gastric acid [55]. Despite the physiological impact of parietal cells, regeneration of parietal cells in organoid culture has rarely been observed. Surprisingly, Hayakawa et al. [49] showed cultured parietal cells in a 3D organoid system. Mist1+ isthmus cells generated H/K ATPase+ parietal cells after 20 days of culture under epidermal growth factor (EGF), Noggin, and jagged canonical notch ligand 1 (Jagged-1), called “ENJ” medium. However, it is uncertain whether cultured parietal cells persist after passaging.

Maintenance of stemness and differentiation in organoid culture are controlled by the established factors such as Wnt, EGF, Noggin, R-spondin, FGF-10, Notch ligand, and Jagged-1 [5,56-59]. It seems that Wnt3A plays a crucial role in maintaining LGR5-derived organoid formation [9]. Single Troy+ chief cells isolated from the corpus gland can maintain their stemness and generate long-lived organoids under Wnt, EGF, Noggin, and R-spondin (WENR) conditions. For differentiation into pit cells, Troy-derived organoids are cultured in Wnt-, FGF-10-, and Noggin-free conditions [47]. Single Mist1+ cells can construct gastric organoids, containing parietal cells and enterochromaffin-like cells, and this phenomenon is dependent on Notch signaling (+ENJ medium) [49]. In WENR medium, Mist1+ isthmus cells do not survive and degenerate [49]. By contrast, Bmi1+ isthmus cells can successfully form organoids even in WENR medium. Ablation of Bmi1+ cells by treatment of diphtheria toxin (DT) significantly reduced organoid counts compared to a non-DT-treated control in the same condition. These results demonstrated that diverse subsets responding to different factors exist in the ASC zone [50].

Nowadays, organoids are considered novel models for improving regenerative medicine. In murine models, emerging results have demonstrated that multiple types of organoids could regenerate injured tissues, including the colon [60], intestine [61], lung [62], and liver [63]. Additionally, cultured gastric organoids exhibited therapeutic effects in mice. Organoid transplantation in injured mice promoted wound healing, and transplanted cells expressed metaplastic cell markers [64], revealing that gastric organoids originating from chief cells can be utilized as a therapeutic strategy.

Human-derived gastric organoids

Organoids can be constructed from 2 sources: pluripotent stem cells (PSCs) or ASCs. ASCs can only generate the specific cells from their tissue of origin, whereas PSCs have the potential to reproduce any cell type. Thus, PSC-derived organoid culture needs a step-wise method to control PSC differentiation into target cells. Some studies have been conducted to develop gastric gland organoids using human ASCs or PSCs.

McCracken et al. [65] proposed a step-wise differentiation approach to reproduce human gastric organoids using PSCs. First, human PSCs were differentiated into endoderm by supplementation of FGF4 and WNT. To acquire foregut from definitive endoderm, Noggin was additionally added to suppress BMP signaling. Finally, the antrum structure was reproduced by EGF and retinoic acid treatment. This organoid method is the first human PSC-derived antrum organoid that recapitulates the host's physiology [66,67]. The method of generating corpus organoids from PSCs is more complicated because the signal cascade required for differentiation is obscure [57]. The cultured organoid contains parietal cells, mucus neck cells, endocrine cells, and chief cells. PSC-derived gastric organoids have been employed to understand the gastric development, physiological mechanism, and host response to pathogens [57,68,69].

Bartfeld et al. [67] developed a long-term culture system using human gastric organoids derived from surgical specimens of the corpus. By inhibiting transforming growth factor-beta signaling, the ASC-derived organoids reproduced the molecular characteristics of their origin site. Tan et al. [35] recently isolated AQP5+ ASC cells from human antrum specimens and maintained AQP5+-derived organoids for more than 3 months. Of note, depletion of Wnt family member 3A (WNT3A), Noggin, and FGF-10 induced differentiation into mucous lineages. According to previous results, the maintenance and differentiation of ASC-derived organoids need simpler steps than those used for PSC-derived organoids. In PSCs, sequential signaling with diverse factors is needed in a timely manner to culture organoids. This is due to the pluripotency of PSCs, which can differentiate into multiple organs. Although the culture process is less complex in ASCs, ASC-derived human organoids have possible defects because ASCs are mostly derived from surgical specimens that are likely to harbor abnormal cells. Therefore, we assume that PSC-derived organoids would be suitable for patient treatment if the culture method is optimized.

H. pylori infection in gastric organoids

A vast variety of organoid models have been established to understand host-microbe interactions, including H. pylori, Cryptosporidium parvum, Salmonella enterica, and Clostridium difficile [70,71]. H. pylori is the primary etiological agent for gastric cancer and infection of Helicobacter species leads to atrophic gastritis and dysplasia in rodent models [16,21]. Mice infected with H. pylori or H. felis developed metaplasia accompanied by parietal cell loss within 20 weeks. In human, H. pylori infection give rise to chronic gastritis and pre-neoplastic metaplasia in the early stage of cancer progression, and infected patients are at greater risk of developing gastric cancer [72]. While in vitro culture methods for H. pylori are well established [73,74], the infection system for host cells still has limitations. Since most gastric cancer cell lines are derived from late stages of cancer, they are not sufficient to represent H. pylori-induced pathogenesis. Animal models are also susceptible to H. pylori, but they take a long time to develop gastric lesions and cannot show real time-pathogenesis. To satisfy the requirements for models in this field, organoid methods have been utilized to study H. pylori and its interaction with carcinogenesis.

Nuclear factor kappa B (NF-κB) induction is a critical step for the development of H. pylori-induced gastritis and is related to chronic infection [75,76]. Bartfeld et al. [67] generated human-derived gastric organoids and microinjected H. pylori into the established organoids. They investigated the primary response of gastric organoids to H. pylori infection and found that interleukin 8 levels, attributable to NF-κB, were increased in gastric organoids. The upregulation of NF-κB was also highlighted in another previous study using murine-derived gastric organoids [77]. H. pylori infection induced sonic-hedgehog (Shh) expression in gastric organoids. This upregulation was suppressed by blockage of NF-κB. Additionally, microinjected H. pylori in human gastric organoids induced an acute host response, including c-Met phosphorylation and proliferation [65].

Real-time screening revealed that injected H. pylori could adhere to the apical cell-cell junctions of human gastric organoids by sensing urea concentrations [78]. After adhesion of H. pylori in gastric organoids, the pathogens promoted proliferation of host epithelial cells via interaction with CD44 [79]. While H. pylori can be grown on human blood plates and in liquid media, the bacteria could not expand their population and ceased proliferation in a conventional eukaryotic culture system [80]. However, H. pylori can expand its population in organoid systems, suggesting that gastric organoids may produce niche factors for H. pylori growth [67,79]. Collectively, these studies indicate that gastric organoids are a useful tool for studying H. pylori infections and simulate important hallmarks of infection.

Conclusion and remarks

Given the results of the past decade, the definition of stem cells and the origin of cancer are more complicated in the corpus than in the antrum. This is because conflicting reports regarding corpus stem cells have been published. We feel that this debate stems from issues in animal models and reagents, such as tamoxifen. Although tamoxifen is a useful reagent for inducing cell-specific lineage tracing, this chemical can elicit severe injury in the corpus and may cause unexpected genetic changes [18]. Recent reports have recognized this problem and used doxycycline-inducible transgenic mice instead of tamoxifen-inducible mice to trace stem cell activity. Nevertheless, contradictory results were still observed. In addition to the tamoxifen issue, the overlapping markers such as Mist1 between isthmus stem cells and chief cells make it difficult to define stem cell zones causing different tracing events in the corpus. We assume that confusing consequences in homeostatic status may be related to the use of different reporter systems [47,49]. However, in terms of tumorigenesis, we speculate that the origin of cancer may be chief cells because pre-neoplastic markers including CD44v9 and WFDC2 are expressed from the base immediately after injury [19,81]. Supporting this, H. pylori shows a strong tropism for metaplastic cells in the base of the corpus [82].

Organoid culture is an emerging tool for research on development, cancer, translational clinical applications, regenerative medicine, and infection biology [83]. Using lineage tracing, researchers have found various markers of gastric stem cells. Presumably, there are more specific markers to be uncovered. Advances in single-cell analysis technology will make it possible to identify more specific subsets of gastric stem cells. Indeed, increasingly many results support the presence of cellular heterogeneity in the stem cell population [84-86]. In light of previous studies, we assume that some subsets derived from chief cells or isthmus cells could generate all lineages of the gastric corpus, including gastric-secreting parietal cells and endocrine cells. Hence, future studies must be conducted using unique subsets and niche factors to better understand gastric physiology and pathogenesis. A few studies have exhibited the presence of cultured parietal cells in organoid systems, but they may not survive and persist after passaging. Since oxyntic atrophy is an initial step in gastric carcinogenesis, it is an urgent task for gastric organoid technology to generate parietal cells in 3D culture systems.

Current organoid technology is still incomplete. Cultured organoids mostly consist of an epithelial layer without essential components of the tissue microenvironment, such as stromal cells and tissue-resident immune cells, which are critical for maintaining homeostasis in the gastrointestinal tract. Despite recent advances in culture protocols, organoid culture systems are still complex and cultured cells have the possibility of transforming after several passages, losing their original characteristics. Furthermore, Matrigel-based organoid culture confers a limitation because the reagent is produced from mouse tumor lines. It remains unclear whether Matrigel has detrimental effects on organoids, which is a barrier to the utilization of organoids as regenerative medicine. Further efforts are needed to solve current hurdles.

Nevertheless, this promising technology has great potential to overcome disease and study pathogenesis. In particular, many stomach cancer patients still undergo surgery and removal of a large portion of the tissue. Patients who have undergone surgery suffer from digestive defects because their tissues do not fully regenerate. Studying the pathogenesis of H. pylori is critical to understand the development of gastric cancer. However, it takes a considerable time (at least 16 weeks after infection) until gastritis emerges in in vivo models. Due to their relatively simple culture systems and regenerative potential, we expect that gastric organoid systems will help to solve these current problems.


Conflict of interest

No potential conflict of interest relevant to this article was reported.


This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2022R1A2C3007850). This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2022R1C1C2009361).

Data availability

Please contact the corresponding author for data availability.


1. Saenz JB, Mills JC. Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 2018;15:257–73.
2. Schepers A, Clevers H. Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb Perspect Biol 2012;4:a007989.
3. Xiao S, Zhou L. Gastric stem cells: physiological and pathological perspectives. Front Cell Dev Biol 2020;8:571536.
4. Willet SG, Mills JC. Stomach organ and cell lineage differentiation: from embryogenesis to adult homeostasis. Cell Mol Gastroenterol Hepatol 2016;2:546–59.
5. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262–5.
6. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med 2011;17:1225–7.
7. Aihara E, Mahe MM, Schumacher MA, Matthis AL, Feng R, Ren W, et al. Characterization of stem/progenitor cell cycle using murine circumvallate papilla taste bud organoid. Sci Rep 2015;5:17185.
8. Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature 2013;501:373–9.
9. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010;6:25–36.
10. Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 2013;494:247–50.
11. Xia Y, Sancho-Martinez I, Nivet E, Rodriguez Esteban C, Campistol JM, Izpisua Belmonte JC. The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells. Nat Protoc 2014;9:2693–704.
12. Weeber F, Ooft SN, Dijkstra KK, Voest EE. Tumor organoids as a pre-clinical cancer model for drug discovery. Cell Chem Biol 2017;24:1092–100.
13. Liu L, Yu L, Li Z, Li W, Huang W. Patient-derived organoid (PDO) platforms to facilitate clinical decision making. J Transl Med 2021;19:40.
14. Mills JC, Shivdasani RA. Gastric epithelial stem cells. Gastroenterology 2011;140:412–24.
15. Soybel DI. Anatomy and physiology of the stomach. Surg Clin North Am 2005;85:875–94.
16. Yoshizawa N, Takenaka Y, Yamaguchi H, Tetsuya T, Tanaka H, Tatematsu M, et al. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest 2007;87:1265–76.
17. Goldenring JR, Ray GS, Coffey RJ, Meunier PC, Haley PJ, Barnes TB, et al. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology 2000;118:1080–93.
18. Huh WJ, Khurana SS, Geahlen JH, Kohli K, Waller RA, Mills JC. Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach. Gastroenterology 2012;142:21–4.
19. Jeong H, Lee B, Kim KH, Cho SY, Cho Y, Park J, et al. WFDC2 promotes spasmolytic polypeptide-expressing metaplasia through the up-regulation of IL33 in response to injury. Gastroenterology 2021;161:953–67.
20. Chang W, Wang H, Kim W, Liu Y, Deng H, Liu H, et al. Hormonal suppression of stem cells inhibits symmetric cell division and gastric tumorigenesis. Cell Stem Cell 2020;26:739–54.
21. Hayakawa Y, Fox JG, Gonda T, Worthley DL, Muthupalani S, Wang TC. Mouse models of gastric cancer. Cancers (Basel) 2013;5:92–130.
22. Zakrzewski W, Dobrzynski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther 2019;10:68.
23. Singh SR. Stem cell niche in tissue homeostasis, aging and cancer. Curr Med Chem 2012;19:5965–74.
24. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105–11.
25. Rossi DJ, Jamieson CH, Weissman IL. Stems cells and the pathways to aging and cancer. Cell 2008;132:681–96.
26. Hayakawa Y, Fox JG, Wang TC. The origins of gastric cancer from gastric stem cells: lessons from mouse models. Cell Mol Gastroenterol Hepatol 2017;3:331–8.
27. Mouse Genome Sequencing Consortium, Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520–62.
28. Perlman RL. Mouse models of human disease: An evolutionary perspective. Evol Med Public Health 2016;2016:170–6.
29. Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, Fox JG, et al. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 2004;127:582–94.
30. Petersen CP, Mills JC, Goldenring JR. Murine models of gastric corpus preneoplasia. Cell Mol Gastroenterol Hepatol 2017;3:11–26.
31. Seidlitz T, Chen YT, Uhlemann H, Scholch S, Kochall S, Merker SR, et al. Mouse models of human gastric cancer subtypes with stomach-specific CreERT2-mediated pathway alterations. Gastroenterology 2019;157:1599–614 e2.
32. Min J, Vega PN, Engevik AC, Williams JA, Yang Q, Patterson LM, et al. Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach. Nat Commun 2019;10:5549.
33. Li XB, Yang G, Zhu L, Tang YL, Zhang C, Ju Z, et al. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice. Cell Res 2016;26:838–49.
34. Leushacke M, Tan SH, Wong A, Swathi Y, Hajamohideen A, Tan LT, et al. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach. Nat Cell Biol 2017;19:774–86.
35. Tan SH, Swathi Y, Tan S, Goh J, Seishima R, Murakami K, et al. AQP5 enriches for stem cells and cancer origins in the distal stomach. Nature 2020;578:437–43.
36. Phesse TJ, Sansom OJ. Lgr5 joins the club of gastric stem cell markers in the corpus. Nat Cell Biol 2017;19:752–4.
37. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, et al. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 2011;9:317–29.
38. Hayakawa Y, Jin G, Wang H, Chen X, Westphalen CB, Asfaha S, et al. CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis. Gut 2015;64:544–53.
39. Jensen KB, Collins CA, Nascimento E, Tan DW, Frye M, Itami S, et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 2009;4:427–39.
40. Wong VW, Stange DE, Page ME, Buczacki S, Wabik A, Itami S, et al. Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 2012;14:401–8.
41. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 2012;149:146–58.
42. Schweiger PJ, Clement DL, Page ME, Schepeler T, Zou X, Sirokmany G, et al. Lrig1 marks a population of gastric epithelial cells capable of long-term tissue maintenance and growth in vitro. Sci Rep 2018;8:15255.
43. Choi E, Lantz TL, Vlacich G, Keeley TM, Samuelson LC, Coffey RJ, et al. Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach. Gut 2018;67:1595–605.
44. Hata M, Kinoshita H, Hayakawa Y, Konishi M, Tsuboi M, Oya Y, et al. GPR30-expressing gastric chief cells do not dedifferentiate but are eliminated via PDK-dependent cell competition during development of metaplasia. Gastroenterology 2020;158:1650–66.
45. Goldenring JR, Nam KT, Mills JC. The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist. Exp Cell Res 2011;317:2759–64.
46. Douchi D, Yamamura A, Matsuo J, Melissa Lim YH, Nuttonmanit N, Shimura M, et al. Induction of gastric cancer by successive oncogenic activation in the corpus. Gastroenterology 2021;161:1907–23.
47. Stange DE, Koo BK, Huch M, Sibbel G, Basak O, Lyubimova A, et al. Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell 2013;155:357–68.
48. Matsuo J, Kimura S, Yamamura A, Koh CP, Hossain MZ, Heng DL, et al. Identification of stem cells in the epithelium of the stomach corpus and antrum of mice. Gastroenterology 2017;152:218–31.
49. Hayakawa Y, Ariyama H, Stancikova J, Sakitani K, Asfaha S, Renz BW, et al. Mist1 expressing gastric stem cells maintain the normal and neoplastic gastric epithelium and are supported by a perivascular stem cell niche. Cancer Cell 2015;28:800–14.
50. Yoshioka T, Fukuda A, Araki O, Ogawa S, Hanyu Y, Matsumoto Y, et al. Bmi1 marks gastric stem cells located in the isthmus in mice. J Pathol 2019;248:179–90.
51. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005;5:899–904.
52. Choi E, Hendley AM, Bailey JM, Leach SD, Goldenring JR. Expression of activated Ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions. Gastroenterology 2016;150:918–30.
53. Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, Finke PE, et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 2010;139:2028–37.
54. Han S, Fink J, Jorg DJ, Lee E, Yum MK, Chatzeli L, et al. Defining the identity and dynamics of adult gastric isthmus stem cells. Cell Stem Cell 2019;25:342–56.
55. Engevik AC, Kaji I, Goldenring JR. The physiology of the gastric parietal cell. Physiol Rev 2020;100:573–602.
56. Merenda A, Fenderico N, Maurice MM. Wnt signaling in 3D: recent advances in the applications of intestinal organoids. Trends Cell Biol 2020;30:60–73.
57. McCracken KW, Aihara E, Martin B, Crawford CM, Broda T, Treguier J, et al. Wnt/beta-catenin promotes gastric fundus specification in mice and humans. Nature 2017;541:182–7.
58. Sato T, Clevers H. SnapShot: growing organoids from stem cells. Cell 2015;161:1700.
59. Schumacher MA, Aihara E, Feng R, Engevik A, Shroyer NF, Ottemann KM, et al. The use of murine-derived fundic organoids in studies of gastric physiology. J Physiol 2015;593:1809–27.
60. Watanabe S, Kobayashi S, Ogasawara N, Okamoto R, Nakamura T, Watanabe M, et al. Transplantation of intestinal organoids into a mouse model of colitis. Nat Protoc 2022;17:649–71.
61. Khalil HA, Hong SN, Rouch JD, Scott A, Cho Y, Wang J, et al. Intestinal epithelial replacement by transplantation of cultured murine and human cells into the small intestine. PLoS One 2019;14e0216326.
62. Kathiriya JJ, Brumwell AN, Jackson JR, Tang X, Chapman HA. Distinct airway epithelial stem cells hide among club cells but mobilize to promote alveolar regeneration. Cell Stem Cell 2020;26:346–58.
63. Nie YZ, Zheng YW, Ogawa M, Miyagi E, Taniguchi H. Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure. Stem Cell Res Ther 2018;9:5.
64. Engevik AC, Feng R, Choi E, White S, Bertaux-Skeirik N, Li J, et al. The development of spasmolytic polypeptide/TFF2-expressing metaplasia (SPEM) during gastric repair is absent in the aged stomach. Cell Mol Gastroenterol Hepatol 2016;2:605–24.
65. McCracken KW, Cata EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 2014;516:400–4.
66. Broda TR, McCracken KW, Wells JM. Generation of human antral and fundic gastric organoids from pluripotent stem cells. Nat Protoc 2019;14:28–50.
67. Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 2015;148:126–36.
68. Dedhia PH, Bertaux-Skeirik N, Zavros Y, Spence JR. Organoid models of human gastrointestinal development and disease. Gastroenterology 2016;150:1098–112.
69. Morey P, Pfannkuch L, Pang E, Boccellato F, Sigal M, Imai-Matsushima A, et al. Helicobacter pylori depletes cholesterol in gastric glands to prevent interferon gamma signaling and escape the inflammatory response. Gastroenterology 2018;154:1391–404.
70. Bartfeld S. Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids. Dev Biol 2016;420:262–70.
71. Aboulkheyr Es H, Montazeri L, Aref AR, Vosough M, Baharvand H. Personalized cancer medicine: an organoid approach. Trends Biotechnol 2018;36:358–71.
72. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175–86.
73. Blanchard TG, Nedrud JG. Laboratory maintenance of helicobacter species. Curr Protoc Microbiol 2006;Chapter 8:Unit8B 1.
74. Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993;34:1032–7.
75. Ferrero RL, Ave P, Ndiaye D, Bambou JC, Huerre MR, Philpott DJ, et al. NF-kappaB activation during acute Helicobacter pylori infection in mice. Infect Immun 2008;76:551–61.
76. Brandt S, Kwok T, Hartig R, Konig W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 2005;102:9300–5.
77. Schumacher MA, Feng R, Aihara E, Engevik AC, Montrose MH, Ottemann KM, et al. Helicobacter pylori-induced Sonic Hedgehog expression is regulated by NFkappaB pathway activation: the use of a novel in vitro model to study epithelial response to infection. Helicobacter 2015;20:19–28.
78. Huang JY, Sweeney EG, Sigal M, Zhang HC, Remington SJ, Cantrell MA, et al. Chemodetection and destruction of host urea allows Helicobacter pylori to locate the epithelium. Cell Host Microbe 2015;18:147–56.
79. Bertaux-Skeirik N, Feng R, Schumacher MA, Li J, Mahe MM, Engevik AC, et al. CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation. PLoS Pathog 2015;11e1004663.
80. Kusters JG, Gerrits MM, Van Strijp JA, Vandenbroucke-Grauls CM. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 1997;65:3672–9.
81. Caldwell B, Meyer AR, Weis JA, Engevik AC, Choi E. Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa. Gut 2022;71:1068–77.
82. Saenz JB, Vargas N, Mills JC. Tropism for spasmolytic polypeptide-expressing metaplasia allows Helicobacter pylori to expand its intragastric niche. Gastroenterology 2019;156:160–74.
83. Seidlitz T, Koo BK, Stange DE. Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine. Cell Death Differ 2021;28:68–83.
84. Yang S, Cho Y, Jang J. Single cell heterogeneity in human pluripotent stem cells. BMB Rep 2021;54:505–15.
85. Norkin M, Capdevila C, Calderon RI, Su T, Trifas M, Ordonez-Moran P, et al. Single-cell studies of intestinal stem cell heterogeneity during homeostasis and regeneration. Methods Mol Biol 2020;2171:155–67.
86. Choi YH, Kim JK. Dissecting cellular heterogeneity using single-cell RNA sequencing. Mol Cells 2019;42:189–99.

Article information Continued

Fig. 1.

Illustrations of the human and mouse stomach. (A) Anatomy of the human and mouse stomach. (B) Images show the distribution of adult stem cells and functional units in the corpus and antrum. The defined molecular markers for adult stem cells and gastric lineage cells are marked in parentheses. Transit-amplifying (TA) cells are an undifferentiated subset in transition between stem cells and differentiated cells. eR1, Runx1 enhance element; GSII, lectin GS-II from Griffonia simplicifolia.

Table 1.

Characteristics of stem cell-derived gastric organoids

Molecular marker Study In vivo location Organoid formation Constructed lineage in organoid Culture medium
Lgr5 Barker et al. [9], 2010 Antrum (base) Yes Undefined WENRF
Leushacke et al. [34], 2017 Corpus (chief cells) Yes Pit cells WENRF
Sox2 Arnold et al. [37], 2011 Corpus and antrum Undefined - -
Troy Stange et al. [47], 2013 Corpus (chief cell) Yes Mucus neck cells, chief cells, pit cells WENRF
Mist1 Hayakawa et al. [49], 2015 Corpus (isthmus) Yes Parietal cells, ECL cells WENR or ENJ
Bmi1 Yoshioka et al. [50], 2019 Corpus (isthmus) Yes Undefined WENR
Antrum (base)
Cck2r Hayakawa et al. [38] 2015 Antrum (base) Yes Undefined WENR
Chang et al. [20], 2020 Antrum (base) Yes Pit cells, endocrine cells, Lgr5+ cells WENRF
Aqp5 Tan et al. [35], 2020 Antrum (base) Yes Pit cells WENRF
Lrig1 Schweiger et al. [42], 2018 Corpus (base) Yes Undefined WENRF
antrum (base)
Choi et al. [43], 2018 Corpus (isthmus) and Undefined - -
antrum (base)
eR1 Matsuo et al. [48], 2017 Corpus (isthmus) Yes Mucus neck cells, chief cells, pit cells WENR or ENJ

W, Wnt3A or Wnt; E, epidermal growth factor; N, Noggin; R, R-spondin; F, fibroblast growth factor-10; ECL, enterochromaffinlike; J, Jagged-1.